Sabah Nisar

3.5k total citations · 5 hit papers
33 papers, 2.2k citations indexed

About

Sabah Nisar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sabah Nisar has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Sabah Nisar's work include Autism Spectrum Disorder Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Sabah Nisar is often cited by papers focused on Autism Spectrum Disorder Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Sabah Nisar collaborates with scholars based in Qatar, United States and India. Sabah Nisar's co-authors include Mohammad Haris, Ajaz A. Bhat, Sheema Hashem, Muzafar A. Macha, Mayank Singh, Tariq Masoodi, Puneet Bagga, Ravinder Reddy, Shahab Uddin and Michael Frenneaux and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Psychiatry and Molecular Cancer.

In The Last Decade

Sabah Nisar

32 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

2022 494 citations Saife N. Lone, Sabah Nisar et al. Molecular Cancer profile →
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents

2022 229 citations Sheema Hashem, Tayyiba Akbar Ali et al. Biomedicine & Pharmacotherapy profile →
Role of NAD+ in regulating cellular and metabolic signaling pathways

2021 219 citations Sabah Nisar, Ajaz A. Bhat et al. Molecular Metabolism profile →
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

2022 135 citations Ajaz A. Bhat, Sabah Nisar et al. profile →
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

2023 108 citations Ashna Gupta, Tariq Masoodi et al. Journal of Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabah Nisar Qatar	21	1.0k	521	504	224	219	33	2.2k
Sheema Hashem Qatar	19	998 1.0×	478 0.9×	505 1.0×	209 0.9×	218 1.0×	29	2.1k
Tsung‐I Hsu Taiwan	28	1.4k 1.4×	459 0.9×	605 1.2×	191 0.9×	314 1.4×	87	2.4k
Tao Qing China	29	976 1.0×	281 0.5×	377 0.7×	142 0.6×	169 0.8×	79	2.8k
Zhuang Miao China	19	1.3k 1.3×	483 0.9×	317 0.6×	287 1.3×	190 0.9×	47	2.4k
Xudong Zhao China	30	1.9k 1.9×	892 1.7×	556 1.1×	603 2.7×	239 1.1×	139	3.7k
Hui Peng China	34	1.4k 1.4×	584 1.1×	359 0.7×	518 2.3×	109 0.5×	90	3.3k
Cong Cao China	33	2.1k 2.1×	377 0.7×	673 1.3×	275 1.2×	236 1.1×	103	3.5k
Yaping Yang China	28	876 0.9×	388 0.7×	345 0.7×	238 1.1×	205 0.9×	107	2.8k
Anna Maria Malfitano Italy	31	1.0k 1.0×	429 0.8×	349 0.7×	292 1.3×	161 0.7×	80	3.0k
Xiaoqian Chen China	33	1.6k 1.6×	239 0.5×	449 0.9×	206 0.9×	288 1.3×	126	3.1k

Countries citing papers authored by Sabah Nisar

Since Specialization

Citations

This map shows the geographic impact of Sabah Nisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabah Nisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabah Nisar more than expected).

Fields of papers citing papers by Sabah Nisar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabah Nisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabah Nisar. The network helps show where Sabah Nisar may publish in the future.

Co-authorship network of co-authors of Sabah Nisar

This figure shows the co-authorship network connecting the top 25 collaborators of Sabah Nisar. A scholar is included among the top collaborators of Sabah Nisar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabah Nisar. Sabah Nisar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashem, Sheema, Ajaz A. Bhat, Sabah Nisar, et al.. (2025). Engineered Anti-Microbial Peptides Inhibit Cell Viability, Promote Apoptosis, and Induce Cell Cycle Arrest in SW620 Human Colon Adenocarcinoma Cells. Current Protein and Peptide Science. 26(7). 570–584.

Burman, Ritambhar, Sabah Nisar, S F Miller, et al.. (2024). Reliability of In Vivo Creatine‐Weighted Chemical Exchange Saturation Transfer (CrCEST) MRI in Calf Skeletal Muscle of Healthy Volunteers at 3 T. Journal of Magnetic Resonance Imaging. 61(4). 1681–1692. 1 indexed citations

Da’as, Sahar, Ikhlak Ahmed, Elbay Aliyev, et al.. (2023). The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature. Journal of Translational Medicine. 21(1). 171–171. 5 indexed citations

Nisar, Sabah & Mohammad Haris. (2023). Neuroimaging genetics approaches to identify new biomarkers for the early diagnosis of autism spectrum disorder. Molecular Psychiatry. 28(12). 4995–5008. 31 indexed citations

Ahmed, Ikhlak, Sahar Da’as, Elbay Aliyev, et al.. (2023). Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease. Computational and Structural Biotechnology Journal. 21. 716–730. 2 indexed citations

Gupta, Ashna, Ravi Chauhan, Ajaz A. Bhat, et al.. (2022). Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis. Figshare. 41 indexed citations

Lone, Saife N., Sabah Nisar, Tariq Masoodi, et al.. (2022). Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular Cancer. 21(1). 79–79. 494 indexed citations breakdown →

Aouida, Mustapha, Ajaz A. Bhat, Sabah Nisar, et al.. (2022). Understanding the Mechanism of Dysglycemia in a Fanconi-Bickel Syndrome Patient. Frontiers in Endocrinology. 13. 841788–841788. 3 indexed citations

Nisar, Sabah, Ajaz A. Bhat, Tariq Masoodi, et al.. (2022). Genetics of glutamate and its receptors in autism spectrum disorder. Molecular Psychiatry. 27(5). 2380–2392. 102 indexed citations

10.

Hashem, Sheema, Tayyiba Akbar Ali, Sabah Akhtar, et al.. (2022). Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy. 150. 113054–113054. 229 indexed citations breakdown →

11.

Nisar, Sabah, Tariq Masoodi, Kirti S. Prabhu, et al.. (2022). Natural products as chemo-radiation therapy sensitizers in cancers. Biomedicine & Pharmacotherapy. 154. 113610–113610. 44 indexed citations

12.

Fatima, Munazza, Ajaz A. Bhat, Sabah Nisar, Khalid A. Fakhro, & Ammira Al‐Shabeeb Akil. (2022). The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile. Heliyon. 9(1). e12698–e12698. 40 indexed citations

13.

Bhat, Ajaz A., Sabah Nisar, Soumi Mukherjee, et al.. (2022). Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics. Journal of Translational Medicine. 20(1). 534–534. 55 indexed citations

14.

Nisar, Sabah, Ajaz A. Bhat, Ab Rauf Shah, et al.. (2021). Role of NAD+ in regulating cellular and metabolic signaling pathways. Molecular Metabolism. 49. 101195–101195. 219 indexed citations breakdown →

15.

Yadav, Santosh K., Ajaz A. Bhat, Sheema Hashem, et al.. (2021). Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder. Translational Psychiatry. 11(1). 349–349. 53 indexed citations

16.

Hashem, Sheema, Sabah Nisar, Ajaz A. Bhat, et al.. (2020). Genetics of structural and functional brain changes in autism spectrum disorder. Translational Psychiatry. 10(1). 229–229. 91 indexed citations

17.

Haris, Mohammad, Sabah Nisar, Sheema Hashem, et al.. (2020). Functional In Vivo Imaging of Tumors. Cancer treatment and research. 180. 3–50. 2 indexed citations

18.

Nisar, Sabah, Ajaz A. Bhat, Sheema Hashem, et al.. (2020). Genetic and Neuroimaging Approaches to Understanding Post-Traumatic Stress Disorder. International Journal of Molecular Sciences. 21(12). 4503–4503. 27 indexed citations

19.

Yadav, Santosh K., Rakesh K. Gupta, Sheema Hashem, et al.. (2020). Brain microstructural changes support cognitive deficits in HIV uninfected children born to HIV infected mothers. Brain Behavior & Immunity - Health. 2. 100039–100039. 11 indexed citations

20.

Bhat, Ajaz A., Najeeb Syed, Lubna Therachiyil, et al.. (2020). Claudin-1, A Double-Edged Sword in Cancer. International Journal of Molecular Sciences. 21(2). 569–569. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact